Vertex Pharmaceuticals Inc
VRTX- 交易所
- Nasdaq
- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0000875320
近 90 天，Vertex Pharmaceuticals Inc 內部人申報 0 筆公開市場買進、1 筆賣出；2026 年第 2 季末有 1,770 家機構在 13F 申報持有，市值合計 $1,197 億；沒有大師持有。
持有 VRTX 5% 以上的大股東
最新一份 Schedule 13D 或 13G 申報持有 Vertex Pharmaceuticals Inc 5% 以上的持有人，依持股比例由大到小；變化是跟這位持有人的上一份申報比。
| 持有人 | 最新表單 | 持股 | 變化 | 首次申報 | 最新申報 | 原文 |
|---|---|---|---|---|---|---|
| Capital World Investors | 13G/A | 10.10%股數 2,570 萬 | −1.10 個百分點原本 11.20% | 2023/2/135 份 | 2026/5/14 | SEC |
| Vanguard Capital Management LLC | 13G | 7.49%股數 1,904 萬 | 新申報 | 2026/4/301 份 | 2026/4/30 | SEC |
| Capital Research Global Investors | 13G/A | 7.00%股數 1,782 萬 | −1.30 個百分點原本 8.30% | 2025/5/134 份 | 2026/11/13 | SEC |
持股是每位持有人最新一份申報的數字。最後一份是舊格式（2024 年 12 月 18 日以前）的持有人沒有持股比例紀錄，不列在這裡；公司被收購或下市之後，持有人通常就不再申報。
13D 與 13G 申報
Vertex Pharmaceuticals Inc 的 26 份 Schedule 13D、13G 申報，由新到舊，包括沒有持股比例的舊格式申報。
| 申報時間（美東） | 申報人 | 表單 | 持股 | 變化 | 事件日 | 原文 |
|---|---|---|---|---|---|---|
| 2026/11/1317:08 ET | Capital Research Global Investors | 13G/A | 7.00%股數 1,782 萬 | −1.30 個百分點原本 8.30% | 2026/9/30 | SEC |
| 2026/5/1413:55 ET | Capital World Investors | 13G/A | 10.10%股數 2,570 萬 | −1.10 個百分點原本 11.20% | 2026/3/31 | SEC |
| 2026/5/1410:19 ET | Capital Research Global Investors | 13G/A | 8.30%股數 2,114 萬 | +1.50 個百分點原本 6.80% | 2026/3/31 | SEC |
| 2026/4/3014:29 ET | Vanguard Capital Management LLC | 13G | 7.49%股數 1,904 萬 | 新申報 | 2026/3/31 | SEC |
| 2026/3/2713:54 ET | Vanguard Group Inc | 13G/A | 0.00%股數 0 | –低於 5% | 2026/3/13 | SEC |
| 2026/2/1210:25 ET | Capital Research Global Investors | 13G/A | 6.80%股數 1,732 萬 | +1.10 個百分點原本 5.70% | 2025/12/31 | SEC |
| 2025/5/1311:32 ET | Capital Research Global Investors | 13G | 5.70%股數 1,454 萬 | 新申報 | 2025/3/31 | SEC |
| 2025/2/1316:53 ET | Capital World Investors | 13G/A | 11.20%股數 2,874 萬 | – | 2024/12/31 | SEC |
| 2025/2/1209:34 ET | FMR LLC等 2 位 | 13G/A | 3.60%股數 922.1 萬 | –低於 5% | 2024/12/31 | SEC |
| 2024/4/10 | Capital World Investors | 13G/A舊制 | – | – | – | SEC |
| 2024/2/13 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2024/2/9 | Capital World Investors | 13G/A舊制 | – | – | – | SEC |
| 2024/2/9 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/1/2513:48 ET | BlackRock Inc. | 13G舊制 | – | – | – | SEC |
| 2023/2/13 | Capital World Investors | 13G舊制 | – | 新申報 | – | SEC |
| 2023/2/9 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2023/2/9 | FMR LLC | 13G舊制 | – | – | – | SEC |
| 2023/1/2413:56 ET | BlackRock Inc. | 13G舊制 | – | – | – | SEC |
| 2022/2/14 | Price T Rowe Associates Inc | 13G/A舊制 | – | – | – | SEC |
| 2022/2/10 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2022/2/9 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2022/2/117:08 ET | BlackRock Inc. | 13G/A舊制 | – | – | – | SEC |
| 2021/2/16 | Price T Rowe Associates Inc | 13G/A舊制 | – | – | – | SEC |
| 2021/2/10 | Vanguard Group Inc | 13G/A舊制 | – | – | – | SEC |
| 2021/2/8 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2021/2/108:23 ET | BlackRock Inc. | 13G/A舊制 | – | – | – | SEC |
Form 144：內部人預計賣出
高階主管、董事與其他關係人預計賣出 Vertex Pharmaceuticals Inc 股票的 190 份通知，由新到舊。
| 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|
| 2026/11/1210:23 ET | Wagner Charles F Jr高階主管 | 1.53 萬 | $837.5 萬 | 2026/11/1210b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/11/610:29 ET | Kewalramani Reshma高階主管 · 董事 | 1.19 萬 | $630.7 萬 | 2026/11/610b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/8/2716:46 ET | Bruce I. Sachs董事 | 1,210 | $66.3 萬 | 2026/8/27 | Goldman Sachs & Co. LLC | SEC |
| 2026/7/216:30 ET | Tatsis Ourania高階主管 | 1,500 | $78.7 萬 | 2026/7/210b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/7/214:16 ET | McKechnie Duncan高階主管 | 1,541 | $80.0 萬 | 2026/7/210b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/7/113:00 ET | Liu Joy高階主管 | 828 | $41.6 萬 | 2026/7/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/6/2609:54 ET | Bozic Carmen高階主管 | 596 | $28.8 萬 | 2026/6/2610b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/6/1811:33 ET | Bozic Carmen高階主管 | 1,020 | $47.1 萬 | 2026/6/1810b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/6/1515:07 ET | Bozic Carmen高階主管 | 4,062 | $182.8 萬 | 2026/6/1510b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/6/514:33 ET | Bozic Carmen高階主管 | 1,745 | $78.5 萬 | 2026/6/510b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/6/114:13 ET | Liu Joy高階主管 | 828 | $36.4 萬 | 2026/6/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/5/2913:31 ET | Bozic Carmen高階主管 | 1,974 | $88.8 萬 | 2026/5/2910b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/5/1510:41 ET | Bozic Carmen高階主管 | 1,354 | $61.4 萬 | 2026/5/1510b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/5/1510:02 ET | Bunnage Mark E.高階主管 | 33 | $1.50 萬 | 2026/5/1510b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/5/1213:11 ET | Bozic Carmen高階主管 | 6,988 | $314.5 萬 | 2026/5/1210b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/5/614:13 ET | Biller Jonathan高階主管 | 5,193 | $220.3 萬 | 2026/5/6 | Fidelity Brokerage Services LLC | SEC |
| 2026/5/410:18 ET | Bhatia Sangeeta N.董事 | 318 | $13.5 萬 | 2026/5/410b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/5/114:28 ET | Liu Joy高階主管 | 1,104 | $46.9 萬 | 2026/5/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/4/113:02 ET | Liu Joy高階主管 | 978 | $43.9 萬 | 2026/4/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/3/2710:32 ET | Bozic Carmen高階主管 | 2,329 | $105.0 萬 | 2026/3/2710b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/3/1311:38 ET | Bozic Carmen高階主管 | 2,329 | $112.2 萬 | 2026/3/1310b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/3/1109:44 ET | McKechnie Duncan高階主管 | 2,633 | $131.2 萬 | 2026/3/1110b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/3/410:09 ET | McKechnie Duncan高階主管 | 2,437 | $115.8 萬 | 2026/3/410b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/3/217:09 ET | Liu Joy高階主管 | 892 | $44.2 萬 | 2026/3/210b5-1 | Fidelity Brokerage Services LLC | SEC |
| 2026/2/2716:41 ET | Kewalramani Reshma高階主管 · 董事 | 4.00 萬 | $1,974 萬 | 2026/2/2710b5-1 | Fidelity Brokerage Services LLC | SEC |
只列最新的 25 份。看 VRTX 近 12 個月的全部通知